(2S)-(+)-Amino-6-iodoacetamidohexanoic acid |  | | SYNONYMS | AIAH | | | | PRODUCT LINE | Nitric Oxide Pathway | | | | PRODUCT FAMILIES | Arginine & Arginases / Related Products | | | | | Ordering Information | | | Product Numbers | Format | Size | Unit Price | Quantity | | | ALX-270-008-M005 |
|
5 mg | | | | | ALX-270-008-M025 |
|
25 mg | | | | | | |
| | | Product Specification | | |
| FORMULA: | C8H15N2O3I | | | | | |
| MW: | 314.1 | | | | | |
| PURITY: | ≥97% | | | | | |
| APPEARANCE: | White solid. | | | | | |
| SOLUBILITY: | Soluble in 6N aq. HCl. | | | | | |
| SHIPPING: | AMBIENT | | | | | |
| LONG TERM STORAGE: | -20°C | | | | | |
| HANDLING: | Protect from light. | | | | | | Product Description | Irreversible inhibitor of arginase. |
| | | Product Specific Literature References | Uterine arginase inhibition affect the rat embryonic development: J.D. Méndez, et al.; Contraception 33, 597 (1986) Abstract
J.G. Trujillo, et al.; Synth. Commun. 21, 683 (1991)
Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase: C.A. Robertson, et al.; BBRC 197, 523 (1993) Abstract
Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages: A. Hrabak, et al.; BBRC 198, 206 (1994) Abstract |
| | | | | RELATED PRODUCT GROUPS | | | | | | |
